- Home
- OPAD vs RADX Comparison
OPAD vs RADX Comparison
Compare OPAD & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- RADX
- Stock Information
- Founded
- OPAD 2015
- RADX 2021
- Country
- OPAD United States
- RADX Australia
- Employees
- OPAD N/A
- RADX N/A
- Industry
- OPAD Real Estate
- RADX
- Sector
- OPAD Finance
- RADX
- Exchange
- OPAD Nasdaq
- RADX NYSE
- Market Cap
- OPAD 25.3M
- RADX 32.5M
- IPO Year
- OPAD N/A
- RADX N/A
- Fundamental
- Price
- OPAD $1.44
- RADX $4.44
- Analyst Decision
- OPAD Hold
- RADX Strong Buy
- Analyst Count
- OPAD 5
- RADX 2
- Target Price
- OPAD $2.38
- RADX $13.50
- AVG Volume (30 Days)
- OPAD 137.7K
- RADX 22.8K
- Earning Date
- OPAD 08-04-2025
- RADX 02-26-2025
- Dividend Yield
- OPAD N/A
- RADX N/A
- EPS Growth
- OPAD N/A
- RADX N/A
- EPS
- OPAD N/A
- RADX N/A
- Revenue
- OPAD $794,159,000.00
- RADX $204,609.00
- Revenue This Year
- OPAD N/A
- RADX N/A
- Revenue Next Year
- OPAD $40.79
- RADX N/A
- P/E Ratio
- OPAD N/A
- RADX N/A
- Revenue Growth
- OPAD N/A
- RADX N/A
- 52 Week Low
- OPAD $0.91
- RADX $3.50
- 52 Week High
- OPAD $5.13
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- OPAD 70.23
- RADX N/A
- Support Level
- OPAD $0.91
- RADX N/A
- Resistance Level
- OPAD $1.59
- RADX N/A
- Average True Range (ATR)
- OPAD 0.13
- RADX 0.00
- MACD
- OPAD 0.06
- RADX 0.00
- Stochastic Oscillator
- OPAD 77.94
- RADX 0.00
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.